CORE LABORATORIES N.V. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-10-22: Form 8-K; Period of report 2014-10-22; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-10-06: Form 8-K; Period of report 2014-10-06; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2014-09-16: Form 8-K; Period of report 2014-09-16; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2014-08-29: Form 8-K; Period of report 2014-08-29; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-10-22 | 8-K | 2014-10-22 | 2.02 Results of Operations and Financial Condition | 2.02 On October 22, 2014, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2014. | clb-2014q3_earningsrelease.htm |
| 2014-10-06 | 8-K | 2014-10-06 | 7.01 Regulation FD Disclosure | 7.01 On October 6, 2014, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.50 per share of common stock for shareholders of record on October 17, 2014 and payable November 25, 2014. | clb-8k_dividend4q2014.htm |
| 2014-09-16 | 8-K | 2014-09-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Mr. C. Brig Miller has notified the Company of his plan to retire, effective April 30, 2015 at age 63, from his position as Vice President, Finance and Chief Accounting Officer & Treasurer of Core Laboratories N.V. (the "Company"). | a8k_clb-officerannouncement.htm |
| 2014-08-29 | 8-K | 2014-08-29 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 On August 29, 2014, Core Laboratories N.V. and Core Laboratories (U.S.) Interests Holdings, Inc. entered into a Sixth Amended and Restated Credit Agreement (henceforth referred to as the “Amended Credit Agreement”) with various financial institutions which are parties to the Amended Credit Agreement (collectively, the “Lenders”), with Bank of America, N.A. also serving as administrative agent for the Lenders, swingline lender and as a letter of credit issuing bank. | a8k_clb-debtannouncement1.htm |
| 2014-07-23 | 8-K | 2014-07-23 | 2.02 Results of Operations and Financial Condition | 2.02 On July 23, 2014, Core Laboratories N.V. issued a press release announcing its financial results for the second quarter of 2014. | clb-2014q2_earningsrelease.htm |
| 2014-07-08 | 8-K | 2014-07-08 | 7.01 Regulation FD Disclosure | 7.01 On July 8, 2014, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.50 per share of common stock for shareholders of record on July 18, 2014 and payable August 18, 2014. | clb-8k_dividend3q2014.htm |
| 2014-05-19 | 8-K | 2014-05-13 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Core Laboratories N.V. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on May 13, 2014 in Amsterdam, The Netherlands. | annualmeetingofshareholder.htm |
| 2014-05-12 | 8-K | 2014-05-12 | 7.01 Regulation FD Disclosure | 7.01 On May 12, 2014, Core Laboratories N.V. issued a press release announcing revisions to previously issued earnings guidance for its 2014 second quarter and full year 2014. | a8-kq22014earningsguidance.htm |
| 2014-04-23 | 8-K | 2014-04-23 | 2.02 Results of Operations and Financial Condition | 2.02 On April 23, 2014, Core Laboratories N.V. issued a press release announcing its financial results for the first quarter of 2014. | clb-2014q1_earningsrelease.htm |
| 2014-04-14 | 8-K | 2014-04-14 | 7.01 Regulation FD Disclosure | 7.01 On April 14, 2014, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.50 per share of common stock for shareholders of record on April 25, 2014 and payable May 23, 2014. | clb-8k_dividend2q2014.htm |
| 2014-01-29 | 8-K | 2014-01-29 | 2.02 Results of Operations and Financial Condition | 2.02 On January 29, 2014, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2013 and full year ended December 31, 2013. | clb-2013q4_earningsrelease.htm |
| 2014-01-13 | 8-K | 2014-01-13 | 7.01 Regulation FD Disclosure | 7.01 On January 13, 2014, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.50 per share of common stock for shareholders of record on January 24, 2014 and payable February 21, 2014. | clb-8k_dividend1q2014.htm |